We Support Your Clients, Providers, and Members
Payers frequently struggle with controlling drug spend and staying compliant amid a constantly evolving regulatory environment. MRIoA's clinical reviews support regulatory adherence while delivering precise, timely pharmacy decisions.
Clinical teams at PBMs face fluctuating PA and appeal volumes, time-sensitive turnaround requirements, complex specialty and rare-disease requests, and constant program changes due to fast-tracked drug approvals.
MRIoA brings licensed clinicians and pharmacy experts, proven intake workflows, and scalable capacity to help you reduce administrative burden, improve decision consistency, and strengthen compliance—while ensuring members get the right therapy at the right time.
Designed for the Operational Reality of PBMs
- Your clinical criteria, drug policies, and formulary structure are applied to reviews, ensuring every determination reflects your program design, including high-demand medications like GLP-1s
- Available capacity to meet fluctuating prior authorization and appeal demand without increasing fixed internal costs
- Specialty-matched reviewers strengthen defensibility and reduce overturn risk
- Licensed pharmacists and physicians review high-cost drugs, gene therapies, and rare disease treatments with rigorous documentation that determines appropriateness or if exception to the criteria is supported
- Workflows that align with state and federal regulations, including Medicare Part D requirements and evolving state mandates
Pharmacy Reviews Configured for Your Lines of Business
MRIoA configures pharmacy review services to fit the unique requirements of each line of business you manage.
How PBMs Partner with MRIoA
We provide scalable clinical resources for rapid integration into your workflows to handle even the highest review volumes.
Pharmacy Reviews
Our multidisciplinary team of pharmacy technicians, pharmacists, physicians and specialists manage initial reviews, first- and second-level reviews, peer-to-peer reviews, and external reviews.
High-Cost Specialty Drug Reviews
Our board-certified physician specialists review high-cost drug requests for complex conditions and rare diseases.
Pharmacy & Therapeutics (P&T) Committee
Our experts evaluate drug policies, review criteria, and conduct clinical evaluation while providing full P&T Committee support.
Built for Timeliness, Quality, and Clinical Rigor
MRIoA’s pharmacy review services give PBMs clinical depth, access to same-state licensed specialists, and high-quality reviews.
Perspectives for PBMs
From Policy to Practice: What Today’s Regulatory Shifts Mean for Clinical and Pharmacy Operations
Deliver Pharmacy Decisions with Confidence
Connect with our team to strengthen your pharmacy review infrastructure and specialty drug governance.


